BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  IFM Therapeutics Appoints Dr. Michael Heneka to Clinical Advisory Board

  Heneka, who serves as Director of the Department of Neurodegenerative Diseases and Gerontopsychiatry at the University Hospital of Bonn, Germany, will join a group of seven distinguished immunotherapy pioneers on the IFM Therapeutics clinical advisory board.

  December 20, 2017

   · 

  3 min read
• Business

  Acticor Biotech Announces Appointment of Dr Yannick Plétan as Chief Medical Officer

  He will report to Gilles Avenard, CEO of Acticor Biotech and be responsible for leading all clinical development and medical affairs at Acticor Biotech.

  December 20, 2017

   · 

  2 min read
• 

  Business

  Bay Area Biotech Forges Exclusive Pact With Zai Lab for Gastric Cancer Drug Development

  Five Prime and Zai Lab today announced an exclusive license agreement for FPA144 in Greater China and global strategic development collaboration.

  December 20, 2017

   · 

  9 min read
• BioCapital

  NORD Awards Five New Grants for Rare Disease Research

  NORD has announced five grantees of its 2017 Rare Disease Research Grant Program.

  December 20, 2017

   · 

  3 min read
• Genetown

  New Patent Issued to AMAG Pharma Entitled “Methods of Reducing Risk of Preterm Birth”

  If approved, the auto-injector will join the Makena portfolio, which also includes the FDA-approved intramuscular injection.

  December 20, 2017

   · 

  6 min read
• Pharm Country

  Precipio Launches its Second New ICE-COLD PCR Targeted Enrichment Kit to Identify Mutations in Lung Cancer Using Liquid (Blood) Biopsies on Sanger Sequencing Platforms

  As part of the transformation of ICP to be platform-agnostic, this kit has been adapted to be used on Sanger Sequencing platforms, a widely used DNA sequencing method in molecular diagnostics.

  December 20, 2017

   · 

  6 min read
• Genetown

  X-Chem Provides Year-End Update on Partnership Achievements

  X-Chem announced that it has licensed its 40th drug discovery program to an undisclosed large Pharma partner, granting exclusive rights to novel small molecules that interact with the partner’s therapeutic target of interest.

  December 20, 2017

   · 

  4 min read
• Deals

  Eloxx Completes Acquisition Transaction With Sevion Therapeutics

  Eloxx today announced the two companies have completed their previously announced acquisition transaction effective as of December 19, 2017.

  December 20, 2017

   · 

  3 min read
• Genetown

  Insulet Corporation to Present at Upcoming Investor Conference on January 9

  Insulet Corporation announced that management will present at the 36th Annual J.P. Morgan Healthcare Conference in San Francisco, California on January 9, 2018, at 4:30pm (Pacific Time).

  December 20, 2017

   · 

  2 min read
• FDA

  FDA Approves Genentech’s Perjeta (pertuzumab) for Adjuvant Treatment of Specific Type of Early Breast Cancer

  Genentech announced the FDA has approved Perjeta (pertuzumab), in combination with Herceptin® (trastuzumab) and chemotherapy (the Perjeta-based regimen).

  December 20, 2017

   · 

  13 min read